Skip to main content
. 2025 Aug 7;13:a26636372. doi: 10.1055/a-2663-6372

Table 2 Adverse events in two groups.

Adverse events Standard monitoring group (n = 899) Capnography monitoring group (n = 888) P value
Any adverse sedation event 29 (3.3) 36 (4.1) 0.374
Vomiting / Retching 1 (0.1) 0 (0) 0.500
Muscle rigidity, Myoclonus 0 (0) 2 (0.2) 0.479
Hypersalivation 0 (0) 1 (0.1) 0.500
Paradoxical response 0 (0) 1 (0.1) 0.500
Prolonged recovery 0 (0) 1 (0.1) 0.500
Failed sedation 0 (0) 2 (0.2) 0.479
Bradycardia 25 (2.8) 24 (2.7) 0.888
Hypotension 5 (0.6) 4 (0.5) 1.000
Ventricular arrhythmias 0 (0) 2 (0.2) 0.479
Tactile stimulation 1 (0.1) 1 (0.1) 1.000
Antisialogogue 0 (0) 1 (0.1) 0.500
Reversal agents 0 (0) 1 (0.1) 0.500
Atropine to treat bradycardia 9 (1.0) 9 (1.0) 0.998
Ephedrine to treat hypotension 5 (0.6) 4 (0.5) 1.000
Intraoperative ventilation change 131 (14.8)
Apnea 603 (67.9)